– ISRAEL – Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the appointment of Holger Liepmann to its Board of Directors, effective February 12, 2015.
Steve Dubin, Enzymotec’s Chairman commented, “I am thrilled to have Mr. Liepmann join our board of directors. The combination of his business knowledge, global leadership skills, and industry contacts will be valuable to the Company and our board. I believe that Mr. Liepmann’s wealth of relevant industry experience will be of great value in helping us develop and support our growth strategies and enhance our leadership positioning in our markets.”
Holger Liepmann said, “As a board member, I am excited to join such a talented and dedicated team. Enzymotec’s technology, product portfolio and focus on innovation have allowed the Company to become a recognized global leader in the large and growing nutritional market. I look forward to utilizing my experience to help the Company execute its strategic growth initiatives.”
Holger Liepmann, age 63, held various positions at Abbott Laboratories from 1986 until his retirement in 2011. From 2006 to 2011, he served as Executive Vice President, Nutritional Products of Abbott Laboratories and reported to the Chief Executive Officer. In this capacity he was responsible for all aspects of Abbott Laboratories’ global nutritional business, including R&D, manufacturing, supply chain and commercial operations. He has held senior management positions in the Pharmaceutical Products Group, Abbott International, the commercial operations for Abbott’s international pharmaceutical business, and Japan Operations. Prior to joining Abbott, he worked for Bayer AG in a variety of capacities between 1975 and 1986. Mr. Liepmann has enjoyed an international career with postings in Japan, Spain, Puerto Rico, Germany and the US. He earned a bachelor’s degree from Dartmouth College and a master’s degree in business administration from Stanford University.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.